Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Petzsch

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|May 19, 2020
CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanismsMargaretha A Skowron, Marieke Vermeulen, Anna Winkelhausen, et al.
Frontiers in Immunology|December 6, 2021
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-CellsCamilla M Grunewald, Corinna Haist, Carolin König, et al.
International Journal of Molecular Sciences|May 5, 2019
HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal TransitionAnanda Ayyappan Jaguva Vasudevan, Michèle J Hoffmann, Michael L C Beck, et al.
Infection and Immunity|September 9, 2025
Lymphotoxin beta receptor<sup>-/-</sup> mice display altered B- and T-cell subpopulations in the bone marrow and peritoneal cavity after <i>Toxoplasma gondii</i> infectionMarcel Helle, Ursula R Sorg, Johannes Ptok, et al.
Scientific Reports|October 11, 2019
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell linesMargaretha A Skowron, Patrick Petzsch, Karin Hardt, et al.
The Journal of Biological Chemistry|April 3, 2024
Engineered interleukin-6-derived cytokines recruit artificial receptor complexes and disclose CNTF signaling via the OSMRPuyan Rafii, Patricia Rodrigues Cruz, Julia Ettich, et al.
Glia|August 14, 2021
Microglia contributes to remyelination in cerebral but not spinal cord ischemiaGoran Pavic, Patrick Petzsch, Robin Jansen, et al.
Communications Biology|April 15, 2023
Cytokimera GIL-11 rescued IL-6R deficient mice from partial hepatectomy-induced death by signaling via non-natural gp130:LIFR:IL-11R complexesPuyan Rafii, Christiane Seibel, Hendrik T Weitz, et al.
International Journal of Molecular Sciences|March 29, 2023
Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer CellsChristian Schrenk, Lukas M Bollmann, Corinna Haist, et al.
Experimental Cell Research|May 4, 2024
Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignanciesMelanie R Müller, Aaron Burmeister, Margaretha A Skowron, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|May 19, 2020
CDK4/6 inhibition presents as a therapeutic option for paediatric and adult germ cell tumours and induces cell cycle arrest and apoptosis via canonical and non-canonical mechanismsMargaretha A Skowron, Marieke Vermeulen, Anna Winkelhausen, et al.
Frontiers in Immunology|December 6, 2021
Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-CellsCamilla M Grunewald, Corinna Haist, Carolin König, et al.
International Journal of Molecular Sciences|May 5, 2019
HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal TransitionAnanda Ayyappan Jaguva Vasudevan, Michèle J Hoffmann, Michael L C Beck, et al.
Infection and Immunity|September 9, 2025
Lymphotoxin beta receptor<sup>-/-</sup> mice display altered B- and T-cell subpopulations in the bone marrow and peritoneal cavity after <i>Toxoplasma gondii</i> infectionMarcel Helle, Ursula R Sorg, Johannes Ptok, et al.
Scientific Reports|October 11, 2019
Distinctive mutational spectrum and karyotype disruption in long-term cisplatin-treated urothelial carcinoma cell linesMargaretha A Skowron, Patrick Petzsch, Karin Hardt, et al.
The Journal of Biological Chemistry|April 3, 2024
Engineered interleukin-6-derived cytokines recruit artificial receptor complexes and disclose CNTF signaling via the OSMRPuyan Rafii, Patricia Rodrigues Cruz, Julia Ettich, et al.
Glia|August 14, 2021
Microglia contributes to remyelination in cerebral but not spinal cord ischemiaGoran Pavic, Patrick Petzsch, Robin Jansen, et al.
Communications Biology|April 15, 2023
Cytokimera GIL-11 rescued IL-6R deficient mice from partial hepatectomy-induced death by signaling via non-natural gp130:LIFR:IL-11R complexesPuyan Rafii, Christiane Seibel, Hendrik T Weitz, et al.
International Journal of Molecular Sciences|March 29, 2023
Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer CellsChristian Schrenk, Lukas M Bollmann, Corinna Haist, et al.
Experimental Cell Research|May 4, 2024
Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignanciesMelanie R Müller, Aaron Burmeister, Margaretha A Skowron, et al.
Pageof 7